Sept 3 (Reuters) - Semnur Pharmaceuticals, a wholly
owned subsidiary of Scilex Holding Company ( SCLX ), will go
public via a merger with special purpose acquisition company
Denali Capital Acquisition Corp in a $2.5 billion deal, the
companies said on Tuesday.